Poehling Capital Management INC. Makes New Investment in Lam Research Corporation $LRCX

Poehling Capital Management INC. acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCX) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 3,300 shares of the semiconductor company’s stock, valued at approximately $1,430,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bayban bought a new position in Lam Research during the fourth quarter worth about $26,000. Vermillion Wealth Management Inc. acquired a new stake in shares of Lam Research in the first quarter valued at approximately $26,000. Cedar Mountain Advisors LLC raised its position in shares of Lam Research by 242.9% in the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 85 shares in the last quarter. Mcguire Capital Advisors Inc. bought a new stake in shares of Lam Research in the fourth quarter valued at approximately $27,000. Finally, Triumph Capital Management acquired a new stake in Lam Research during the third quarter worth approximately $27,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Activity at Lam Research

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares of the company’s stock, valued at $29,192,570. This represents a 17.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the sale, the senior vice president owned 58,470 shares in the company, valued at $18,102,312. This represents a 11.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 80,441 shares of company stock valued at $27,614,296 in the last quarter. Insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

Lam Research stock opened at $327.92 on Wednesday. Lam Research Corporation has a 12-month low of $94.11 and a 12-month high of $438.50. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The business’s 50-day moving average price is $339.86 and its two-hundred day moving average price is $284.93. The stock has a market cap of $410.33 billion, a PE ratio of 56.93, a P/E/G ratio of 1.32 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. During the same quarter in the previous year, the firm earned $1.33 earnings per share. The business’s quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

LRCX has been the topic of a number of recent research reports. BNP Paribas Exane raised their price objective on Lam Research from $250.00 to $260.00 and gave the stock a “neutral” rating in a research note on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $320.00 target price on shares of Lam Research in a report on Thursday, July 30th. JPMorgan Chase & Co. boosted their price target on Lam Research from $300.00 to $315.00 and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Stifel Nicolaus upped their price objective on shares of Lam Research from $325.00 to $425.00 and gave the stock a “buy” rating in a research report on Friday, July 10th. Finally, Berenberg Bank increased their price objective on shares of Lam Research from $265.00 to $335.00 and gave the stock a “buy” rating in a research note on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $358.47.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.